SUBSCRIBE
SUBSCRIBE
News   Drug Development

ReNeuron Reports Encouraging Signs From Parkinson’s Disease Programme

February 16, 2006 | 
1 min read
ReNeuron Group PLC said the stem cells it is working on to find a treatment for Parkinson's disease have shown attributes that could be used to reverse the effects of the illness.
Preclinical Europe
MORE ON THIS TOPIC
Insights
Inside the Race to Build the Next Generation of AI Drug Discovery Platforms
March 19, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Prohibition sign. Halftone hands cross their fingers in a no entry sign. Refusal, stop gesture. Rejection sign. Warning concept. Newspaper collage
FDA
Third FDA Rejection for Aldeyra’s Dry Eye Disease Drug Sends Shares Plummeting
March 17, 2026
 · 
2 min read
 · 
Heather McKenzie
Cambridge, USA - 8 July 2025. Pfizer office entrance with logo on a modern glass building, surrounded by greenery.
Breast cancer
Pfizer’s Ibrance Heir Reduces Risk of Death in Phase 2 Breast Cancer Test
March 17, 2026
 · 
1 min read
 · 
Annalee Armstrong
Abstract creative art collage, market declines in the stock market. The concept of collapse or bankruptcy.
Obesity
Rhythm’s Imcivree Fails Late-Stage Weight Loss Trial in Rare Obesities
March 17, 2026
 · 
2 min read
 · 
Tristan Manalac